AU2002328630A1 - Method of diagnosing or monitoring saccharometabolic error - Google Patents
Method of diagnosing or monitoring saccharometabolic errorInfo
- Publication number
- AU2002328630A1 AU2002328630A1 AU2002328630A AU2002328630A AU2002328630A1 AU 2002328630 A1 AU2002328630 A1 AU 2002328630A1 AU 2002328630 A AU2002328630 A AU 2002328630A AU 2002328630 A AU2002328630 A AU 2002328630A AU 2002328630 A1 AU2002328630 A1 AU 2002328630A1
- Authority
- AU
- Australia
- Prior art keywords
- saccharometabolic
- diagnosing
- error
- monitoring
- saccharometabolic error
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001248047 | 2001-08-17 | ||
| JP2001-248047 | 2001-08-17 | ||
| PCT/JP2002/008331 WO2003016906A1 (en) | 2001-08-17 | 2002-08-16 | Method of diagnosing or monitoring saccharometabolic error |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002328630A1 true AU2002328630A1 (en) | 2003-05-29 |
| AU2002328630B2 AU2002328630B2 (en) | 2005-09-01 |
Family
ID=19077272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002328630A Ceased AU2002328630B2 (en) | 2001-08-17 | 2002-08-16 | Method of diagnosing or monitoring saccharometabolic error |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7067634B2 (en) |
| EP (1) | EP1426764B1 (en) |
| JP (1) | JP3624216B2 (en) |
| AT (1) | ATE504001T1 (en) |
| AU (1) | AU2002328630B2 (en) |
| CA (1) | CA2459489C (en) |
| DE (1) | DE60239622D1 (en) |
| DK (1) | DK1426764T3 (en) |
| ES (1) | ES2361663T3 (en) |
| WO (1) | WO2003016906A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1607742E (en) | 2003-03-24 | 2012-01-19 | Otsuka Pharma Co Ltd | Latex reagent for adiponectin analysis and method of adiponectin analysis |
| WO2004096272A2 (en) * | 2003-04-29 | 2004-11-11 | Cytos Biotechnology Ag | Methods and compositions for modulating the interaction between adiponectin and its receptor |
| WO2005094200A2 (en) * | 2003-06-20 | 2005-10-13 | University Of Florida | Biomarkers for differentiating between type 2 and type 2 diabetes |
| US7176292B2 (en) * | 2003-09-11 | 2007-02-13 | Dialean, Ltd. | Ghrelin variant protein |
| EP2071333B1 (en) * | 2003-10-15 | 2012-04-18 | Sekisui Medical Co., Ltd. | Method of selectively assaying adiponectin multimers |
| US7781171B2 (en) | 2003-10-15 | 2010-08-24 | Daiichi Pure Chemicals Co., Ltd. | Mehod of pretreating sample and immunological assay method using the same |
| DE602004022968D1 (en) * | 2003-11-07 | 2009-10-15 | Merck & Co Inc | IE TREATMENT MTI INSULIN SENSITIZERS |
| WO2005092367A1 (en) * | 2004-03-29 | 2005-10-06 | Fuji Oil Company, Limited | Composition for promoting adiponectin secretion |
| EP1744160B1 (en) * | 2004-03-31 | 2011-07-06 | Kazuhisa Maeda | Use of adiponectin as marker in the prediction of post-operative infection |
| US8563581B2 (en) * | 2005-02-02 | 2013-10-22 | Mitos Pharmaceuticals, Inc. | Nitroxides for use in treating predisposed or at risk patients |
| GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
| CA2707182C (en) * | 2007-11-30 | 2017-12-12 | Siemens Healthcare Diagnostics Inc. | Adiponectin receptor fragments and methods of use |
| CN102388308B (en) | 2009-04-23 | 2015-08-19 | 西门子医疗保健诊断公司 | Adiponectin receptor fragments in monomeric and dimeric forms and methods of use |
| JP5824359B2 (en) | 2009-05-07 | 2015-11-25 | 株式会社Lsiメディエンス | Novel monoclonal antibodies and their use for the analysis of macromolecular adiponectin |
| JP5048100B2 (en) | 2010-04-28 | 2012-10-17 | シャープ株式会社 | Peptide having binding property to adiponectin, and analysis method and analyzer using the peptide |
| RU2553943C1 (en) * | 2014-05-27 | 2015-06-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО МГМУ им. И.М. Сеченова) | Diagnostic technique for insulin resistance |
| AU2020223826A1 (en) * | 2019-02-18 | 2021-08-05 | The University Of Liverpool | Method of diagnosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE98950411T1 (en) | 1997-10-29 | 2005-10-20 | Otsuka Pharma Co Ltd | A composition for inhibiting smooth muscle proliferation, methods for diagnosing arteriosclerosis, and kits therefor |
| WO2001032868A1 (en) * | 1999-11-04 | 2001-05-10 | Genset | Apm1 biallelic markers and uses thereof |
-
2002
- 2002-08-16 ES ES02762796T patent/ES2361663T3/en not_active Expired - Lifetime
- 2002-08-16 JP JP2003521362A patent/JP3624216B2/en not_active Expired - Lifetime
- 2002-08-16 CA CA002459489A patent/CA2459489C/en not_active Expired - Fee Related
- 2002-08-16 EP EP02762796A patent/EP1426764B1/en not_active Expired - Lifetime
- 2002-08-16 DK DK02762796.7T patent/DK1426764T3/en active
- 2002-08-16 AU AU2002328630A patent/AU2002328630B2/en not_active Ceased
- 2002-08-16 DE DE60239622T patent/DE60239622D1/en not_active Expired - Lifetime
- 2002-08-16 US US10/487,039 patent/US7067634B2/en not_active Expired - Lifetime
- 2002-08-16 AT AT02762796T patent/ATE504001T1/en not_active IP Right Cessation
- 2002-08-16 WO PCT/JP2002/008331 patent/WO2003016906A1/en not_active Ceased
-
2005
- 2005-06-22 US US11/157,947 patent/US7435551B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002360634A1 (en) | System for monitoring physiological characteristics | |
| AU2002328630A1 (en) | Method of diagnosing or monitoring saccharometabolic error | |
| AU2002367180A1 (en) | Concentration measuring method | |
| EP1434989B8 (en) | Method and apparatus for diagnosing hemostasis | |
| AU2002352446A1 (en) | System and method for monitoring usage patterns | |
| AU2003283235A1 (en) | Method for monitoring sensor function | |
| GB0106817D0 (en) | Monitoring method | |
| AU2002324228A1 (en) | Health monitoring system | |
| AU2002366398A1 (en) | Structural health monitoring | |
| AUPR958601A0 (en) | Remote monitoring | |
| AU2002327860A1 (en) | Diagnostic methods | |
| EP1376555B8 (en) | Offset measuring method | |
| AU2002323855A1 (en) | Method for diagnosing the functional condition of an organism | |
| AU2002219357A1 (en) | Monitoring system | |
| AU2002307540A1 (en) | Method for evaluating personnel | |
| AU2002344611A1 (en) | Method of diagnosing type 2 diabetes | |
| AU2002251169A1 (en) | Monitoring method | |
| AUPS236502A0 (en) | Method of monitoring measurements | |
| AUPR783601A0 (en) | Prognostic method | |
| AU2002244989A1 (en) | Method of contact monitoring | |
| AUPR417601A0 (en) | Method of diagnosing mastitis | |
| AU2002340755A1 (en) | Method for monitoring an automation unit | |
| AU2002332832A1 (en) | Method of diagnosing nephrotic syndrome | |
| AU2003266059A1 (en) | Method of diagnosing osteolysis | |
| HK1064073A (en) | Condition monitoring system |